You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGF816

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • EGF816
  • +5 more
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Lung Cancer Trial in Boston (EGF816, Gefitinib)

Active, not recruiting
  • Lung Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 21, 2022

Advanced NSCLC Trial in Worldwide (EGF816)

Active, not recruiting
Has Results
  • Advanced Non-small Cell Lung Cancer
  • EGF816
  • Boston, Massachusetts
  • +13 more
Oct 21, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • EGF816
  • +2 more
  • Houston, Texas
  • +12 more
Jan 31, 2022

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

Completed
  • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
  • PDR001
  • +4 more
  • Baltimore, Maryland
  • +22 more
Mar 15, 2022

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

Carcinoma, Non-small Cell Lung Trial (EFG816, erlotinib or gefitinib)

Withdrawn
  • Carcinoma, Non-small Cell Lung
  • (no location specified)
Nov 21, 2019

Mediastinal Lymphadenopathy, Hilar Lymphadenopathy, Lymphoma Trial in Ancona (No suction EBUS-TBNA, Passive suction through

Not yet recruiting
  • Mediastinal Lymphadenopathy
  • +9 more
  • No suction EBUS-TBNA
  • +2 more
  • Ancona, Italy
    Pulmonary Diseases Unit, Department of Immunoallergic and Respir
May 25, 2022

Ischemic Stroke; Ischemic Attack, Transient Trial in Worldwide (Milvexian, Placebo)

Not yet recruiting
  • Ischemic Stroke; Ischemic Attack, Transient
  • Tucson, Arizona
  • +599 more
Jan 19, 2023

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
  • Ulcerative Colitis
  • Dothan, Alabama
  • +406 more
Jan 11, 2022

Acute Coronary Syndrome Trial in Worldwide (Milvexian, Placebo)

Not yet recruiting
  • Acute Coronary Syndrome
  • Alexander City, Alabama
  • +862 more
Feb 23, 2023

Atrial Fibrillation Trial in Worldwide (Milvexian, Apixaban, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • Alexander City, Alabama
  • +1158 more
Feb 24, 2023

Tooth Loss, Edentulous Jaw Trial (Piezosurgery, Drill)

Completed
  • Tooth Loss
  • Edentulous Jaw
  • Piezosurgery
  • Drill
  • (no location specified)
May 15, 2018